Skip to content
10-Q

Quarterly Report

ACADIA PHARMACEUTICALS INC ACAD

0000950170-25-104295

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 30, 2025 168.71M sh
Shares Diluted Q2 2025 · Jun 30, 2025 168.68M sh
Shares Diluted Q2 2025 · Jun 30, 2025 168.22K sh
Shares Diluted Q2 2025 · Jun 30, 2024 166.17M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 166.39K sh
Capex Q2 2025 · Jun 30, 2025 $297K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 $84.28M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $54.09M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $253.64M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $319.59M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $177.13M
Cash And Equivalents Q2 2025 · Dec 31, 2023 $188.66M
Stockholders Equity Q2 2025 · Jun 30, 2025 $822.38M
Stockholders Equity Q2 2025 · Mar 31, 2025 $765.24M
Stockholders Equity Q2 2025 · Dec 31, 2024 $732.79M
Stockholders Equity Q2 2025 · Jun 30, 2024 $516.7M
Stockholders Equity Q2 2025 · Mar 31, 2024 $464.04M
Stockholders Equity Q2 2025 · Dec 31, 2023 $431.76M
Current Liabilities Q2 2025 · Jun 30, 2025 $330.02M
Current Liabilities Q2 2025 · Dec 31, 2024 $394.87M
Total Liabilities Q2 2025 · Jun 30, 2025 $403.17M
Total Liabilities Q2 2025 · Dec 31, 2024 $454.96M
Current Assets Q2 2025 · Jun 30, 2025 $960.55M
Current Assets Q2 2025 · Dec 31, 2024 $938.32M
Total Assets Q2 2025 · Jun 30, 2025 $1.23B
Total Assets Q2 2025 · Dec 31, 2024 $1.19B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.16
Eps Diluted Q2 2025 · Jun 30, 2025 $0.27
Eps Diluted Q2 2025 · Jun 30, 2024 $0.20
Eps Diluted Q2 2025 · Jun 30, 2024 $0.30
Eps Basic Q2 2025 · Jun 30, 2025 $0.16
Eps Basic Q2 2025 · Jun 30, 2025 $0.27
Eps Basic Q2 2025 · Jun 30, 2024 $0.20
Eps Basic Q2 2025 · Jun 30, 2024 $0.30
Sga Expense Q2 2025 · Jun 30, 2025 $133.51M
Sga Expense Q2 2025 · Jun 30, 2025 $259.88M
Sga Expense Q2 2025 · Jun 30, 2024 $117.06M
Sga Expense Q2 2025 · Jun 30, 2024 $225.05M
Rd Expense Q2 2025 · Jun 30, 2025 $77.95M
Rd Expense Q2 2025 · Jun 30, 2025 $156.22M
Rd Expense Q2 2025 · Jun 30, 2024 $76.23M
Rd Expense Q2 2025 · Jun 30, 2024 $135.91M
Net Income Q2 2025 · Jun 30, 2025 $26.67M
Net Income Q2 2025 · Jun 30, 2025 $45.65M
Net Income Q2 2025 · Jun 30, 2024 $33.39M
Net Income Q2 2025 · Jun 30, 2024 $49.94M
Operating Income Q2 2025 · Jun 30, 2025 $32.37M
Operating Income Q2 2025 · Jun 30, 2025 $51.66M
Operating Income Q2 2025 · Jun 30, 2024 $30.44M
Operating Income Q2 2025 · Jun 30, 2024 $45.65M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $20.73M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $41.13M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $18.23M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $41.18M
Revenue Q2 2025 · Jun 30, 2025 $264.57M
Revenue Q2 2025 · Jun 30, 2025 $508.88M
Revenue Q2 2025 · Jun 30, 2024 $241.96M
Revenue Q2 2025 · Jun 30, 2024 $447.79M